Changes in thyroid function and evolution of subclinical thyroid disease in older men

OBJECTIVE: Prevalence of subclinical thyroid disease increases with age, but optimal detection and surveillance strategies remain unclear particularly for older men.

We aimed to assess thyroid stimulating hormone (TSH) and free thyroxine (FT4) concentrations and their longitudinal changes, to determine the prevalence and incidence of subclinical thyroid dysfunction in older men.

DESIGN, PARTICIPANTS AND MEASUREMENTS: Longitudinal study of 994 community‐dwelling men aged ≥70 years without known or current thyroid disease, with TSH and FT4 concentrations assessed at baseline and follow‐up (after 8.7 ± 0.9 years).

Factors associated with incident subclinical thyroid dysfunction were examined by logistic regression and receiver operating characteristic analyses.

RESULTS: At baseline, 85 men (8.6%) had subclinical hypothyroidism and 10 (1.0%) subclinical hyperthyroidism.

Among 899 men euthyroid at baseline (mean age 75.0 ± 3.0 years), 713 (79.3%) remained euthyroid, 180 (20.0%) developed subclinical/overt hypothyroidism, and 6 (0.7%) subclinical/overt hyperthyroidism.

Change in TSH correlated with baseline TSH (r = .16, p < .05).

Change in FT4 correlated inversely with baseline FT4 (r = −0.35, p < .05).

Only higher age and baseline TSH predicted progression from euthyroid to subclinical/overt hypothyroidism (fully‐adjusted odds ratio [OR] per year=1.09, 95% confidence interval [CI] = 1.02‐1.17, p = .006; per 2.7‐fold increase in TSH OR = 65.4, CI = 31.9‐134, p < .001).

Baseline TSH concentration ≥2.34 mIU/L had 76% sensitivity and 77% specificity for predicting development of subclinical/overt hypothyroidism.

CONCLUSIONS: In older men TSH concentration increased over time, while FT4 concentration showed little change.

Subclinical or overt hypothyroidism evolved in one fifth of initially euthyroid men, age and higher baseline TSH predicted this outcome.

Increased surveillance for thyroid dysfunction may be justified in older men, especially those with high‐normal TSH.